Dr. Nancy L. Lewis Appointed NCCN Chief Scientific Officer Starting May 2026

The National Comprehensive Cancer Network (NCCN) has announced the appointment of Dr. Nancy L. Lewis, MD, MBS, FACP, as its Chief Scientific Officer (CSO), effective May 2026. This decision introduces a new leadership role within the organization aimed at advancing scientific innovation and strengthening translational research efforts in oncology. Dr. Lewis brings extensive experience in cancer research and clinical practice to her new position.

Dr. Lewis is recognized for her contributions to oncology and her expertise in fostering collaboration between research and clinical applications. Her appointment reflects NCCN’s commitment to enhancing its scientific initiatives and addressing evolving challenges in cancer care. The organization has stated that this strategic move aligns with its mission to improve patient outcomes through evidence-based practices and cutting-edge research.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 9, 2026

Author

GOAI